$6.37
-0.02-0.31%
Últ. Act.: Oct 20, 4:00 PM
$6.37
-0.02-0.31%
Lifecore Biomedical (LFCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Lifecore Biomedical (LFCR) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $120M - $125M para el período.
En comparación con la previsión anterior, Lifecore Biomedical mantenido redujo su previsión de ingresos desde un rango anterior de $120M - $125M.
Lifecore Biomedical ha emitido 7 actualizaciones de orientación entre el abril 1, 2024 y el agosto 5, 2026. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.21 | $-0.28 | — | $-0.30 |
| Actual | $-0.19 | $-0.43 | $-0.16 | $-0.29 |
| Surprise | +9.52% | -53.6% | — | +3.33% |
| Revenue | ||||
| Estimate | $32.1M | $26.3M | — | $26.6M |
| Actual | $34.2M | $23.2M | $35.7M | $31.1M |
| Surprise | +6.71% | -11.8% | — | +17.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.31 | $-0.09 | $-0.30 | $-0.22 |
| Revenue | ||||
| Consensus | $25.5M | $38.1M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.19 | $-0.21 | 9.52 % |
| Q1 | May 6, 2026 | $-0.43 | $-0.28 | -53.6 % |
| Q1 | Nov 6, 2025 | $-0.29 | $-0.30 | 3.33 % |
| Q4 | Aug 7, 2025 | $-0.06 | $-0.09 | 33.3 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $34.20M | $32.05M | 6.71 % |
| Q1 | May 6, 2026 | $23.19M | $26.30M | -11.8 % |
| Q1 | Nov 6, 2025 | $31.11M | $26.56M | 17.2 % |
| Q4 | Aug 7, 2025 | $36.44M | $35.52M | 2.61 % |